English (United States)
 

Clinical trials: clearer rules, better protection for patients

15.04.14
reduce font Size enlarge font Size print content
 
NWI5563HM87RD464.jpg

MEPs vote for more transparency in European Clinical Trials

Members of the European Parliament have by a huge majority voted for the adoption of the new Clinical Trials Regulation. Among other novelties, the new law requires publishing results of all European clinical trials in a publicly-accessible database within one year of the trials end.

Please find the official press release from the 2nd of April 2014 under following link:

http://www.europarl.europa.eu/news/en/news-room/content/20140331IPR41186/html/Clinical-trials-clearer-rules-better-protection-for-patients

Please find more information about requirement of the new law on the AllTrials campaign website:

http://www.alltrials.net/2014/europe-votes-for-clinical-trial-transparency/

 

 

Who should register?

Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.

Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.